Correlation Between Pfizer and Fairfax Fin

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Fairfax Fin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Fairfax Fin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and Fairfax Fin Hld, you can compare the effects of market volatilities on Pfizer and Fairfax Fin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Fairfax Fin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Fairfax Fin.

Diversification Opportunities for Pfizer and Fairfax Fin

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Fairfax is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Fairfax Fin Hld in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fairfax Fin Hld and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Fairfax Fin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fairfax Fin Hld has no effect on the direction of Pfizer i.e., Pfizer and Fairfax Fin go up and down completely randomly.

Pair Corralation between Pfizer and Fairfax Fin

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Fairfax Fin. In addition to that, Pfizer is 1.32 times more volatile than Fairfax Fin Hld. It trades about -0.06 of its total potential returns per unit of risk. Fairfax Fin Hld is currently generating about 0.13 per unit of volatility. If you would invest  1,343  in Fairfax Fin Hld on September 12, 2024 and sell it today you would earn a total of  832.00  from holding Fairfax Fin Hld or generate 61.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  Fairfax Fin Hld

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Fairfax Fin Hld 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fairfax Fin Hld are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Fairfax Fin sustained solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Fairfax Fin Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Fairfax Fin

The main advantage of trading using opposite Pfizer and Fairfax Fin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Fairfax Fin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fairfax Fin will offset losses from the drop in Fairfax Fin's long position.
The idea behind Pfizer Inc CDR and Fairfax Fin Hld pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges